HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
COVID-19 Impact on World-Wide Pharma Companies

The COVID-19 pandemic influenced the year 2020, and Pharma was not only at the vanguard of attempts to combat the virus, but it was also vulnerable to the impacts of lockdowns. The hunt for a vaccine displaced existing capacity and clinical development programs, but it sparked unprecedented industrial collaboration. It also showcased the industry's remarkable adaptability and innovation. Long-term effects of the COVID-19 pandemic on the pharmaceutical sector in both global and local levels could include slowed industry growth, delays in approvals, and self-sufficiency in the pharm-production supply chain, as well as trend changes in health-market product consumption and ethical crises.

Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - A C Matin

A C Matin

Stanford University School of Medicine, Canada
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Consolato M Sergi

Consolato M Sergi

Children's Hospital of Eastern Ontario, University of Ottawa, Canada
Pharma 2022 Speakers
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - A C Matin

A C Matin

Stanford University School of Medicine, Canada
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Consolato M Sergi

Consolato M Sergi

Children's Hospital of Eastern Ontario, University of Ottawa, Canada
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Phila Raharivelomanana

Phila Raharivelomanana

University of French Polynesia, French Polynesia
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Ruchika Bajaj

Ruchika Bajaj

University of California, United States
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2022 - Mirela Olympia Fagarasan Palmer

Mirela Olympia Fagarasan Palmer

University of Southern California, United States

Submit your abstract Today

Watsapp